Common Contracts
2 similar Sixth Supplemental Indenture contracts by Valeant Pharmaceuticals International, Inc.
SIXTH SUPPLEMENTAL INDENTURESixth Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
SIXTH SUPPLEMENTAL INDENTURE, dated as of July 26, 2013 (the “Sixth Supplemental Indenture”), by and among Obagi Medical Products, Inc. (“Obagi”), OMP, Inc. (“OMP”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
SIXTH SUPPLEMENTAL INDENTURESixth Supplemental Indenture • November 1st, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • New York
SIXTH SUPPLEMENTAL INDENTURE, dated as of July 26, 2013 (the “Sixth Supplemental Indenture”), by and among Obagi Medical Products, Inc. (“Obagi”), OMP, Inc. (“OMP”), Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), and The Bank of New York Mellon Trust Company, N.A., a national banking association, as trustee (the “Trustee”).
